Increased Microvascular Resistance and HbA1c Levels Predict Poor Outcomes in Diabetic STEMI Patients

Overview

This study identifies elevated angiography-derived microvascular resistance (AMR) and HbA1c levels as significant predictors of major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with type 2 diabetes mellitus (T2DM) and ST-segment elevation myocardial infarction (STEMI).

Background

The mortality rate associated with acute ST-segment elevation myocardial infarction (STEMI) is increasing globally, particularly among patients with type 2 diabetes mellitus (T2DM). These patients are at a heightened risk for adverse clinical outcomes due to coronary microvascular dysfunction. Understanding the prognostic value of microvascular resistance and glycemic control is crucial.

Data Highlights

Key Findings

• Elevated AMR is independently associated with MACCEs in diabetic STEMI patients.
• HbA1c levels ≥6.5% significantly increase the risk of MACCEs.
• Nonlinear relationships exist between MACCEs and both HbA1c and AMR levels.
• Combined evaluation of AMR and HbA1c enhances risk stratification for MACCEs.
• Coronary microvascular dysfunction is prevalent in T2DM patients with STEMI.

Clinical Implications

Assessing AMR and HbA1c levels can provide insights for risk stratification in diabetic patients post-STEMI.

Conclusion

The study highlights the importance of evaluating microvascular resistance and glycemic control in predicting adverse outcomes in diabetic patients with STEMI.

Related Resources & Content

1. Clinical Research in Cardiology, 2025 -- Effects of Diabetes on Clinical Outcomes in Patients with ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
2. Clinical Research in Cardiology, 2025 -- Forecasting MRI-identified microvascular obstruction and its long-term consequences following acute myocardial infarction
3. Clinical Research in Cardiology, 2023 -- Physiology-Guided Percutaneous Coronary Intervention in Diabetic Patients with Intermediate Coronary Artery Disease
4. Hub - 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
5. Frontiers in Cardiovascular Medicine — Effect of stress-induced hyperglycaemia on clinical outcome in paitients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
6. Hub - 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - Professional Heart Daily | American Heart Association
7. Index of Microcirculatory Resistance to predict microvascular obstruction in STEMI: A systematic review and meta-analysis - PubMed
8. Frontiers | Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis